Serum tryptase: An indicator of anaphylaxis following fluorescein angiography

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 237, Issue 5, 1999, Pages 433-434

  Butrus, Salim I ^a,b   Negvesky, Gerald J ^a   Rivera Velazques, Pedro M ^a   Schwartz, Lawrence B ^c  

^a Georgetown Washington National Eye Center   (United States)

^b Virginia Commonwealth University ^*  (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; TRYPTASE;

ADULT; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; CASE REPORT; CELL ACTIVATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HUMAN TISSUE; MAST CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SERUM;

ANAPHYLAXIS; BIOLOGICAL MARKERS; CHYMASES; CONTRAST MEDIA; FEMALE; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; INJECTIONS, INTRAVENOUS; MAST CELLS; MIDDLE AGED; RADIOIMMUNOASSAY; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0032943132     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050256     Document Type: Article

References (8)

1. Castells MC, Irani AM, Schwartz LB (1987) Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 138: 2184-2189
2. Kwiterovich KA, Maguire MG, Murphy RP, et al (1991) Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology 98: 1139-1142
3. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T (1987) Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316: 1622-1626
4. Schwartz LB, Sakai K, Bradford TR, et al (1995) The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 96: 2702-2710
5. Schwartz LB, Yunginger JW, Miller JS, Bokhari R, Dull D (1989) The time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83: 1551-1555
6. Van der Linden P-WG, Hack CE, Poortman J, Vivie-Kipp YC, Struyvenberg A, Van der Zwan JK (1992) Insectsting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 90: 110-118
7. Xia H-Z, Kepley CL, Sakai K, Chelliah J, Irani A-MA, Schwartz LB (1995) Quantitation of tryptase, chymase, FcεRIα, and FcεRIgamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 154: 5472-5480
8. Yannuzzi LA, Rohrer KT, Tindel LJ, et al (1986) Fluorescein angiography complication survey. Ophthalmology 93: 611-617